Director, epidemiology
Gilead Sciences, Inc.
Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Public Company)
Mark Berry, PhD, MPH, Director of Epidemiology, Emerging Viruses, at Gilead Sciences. Mark has been at Gilead for 2 years. He worked at the Centers for Disease Control and Prevention for 8 years previously, and received his PhD in epidemiology from Johns Hopkins Bloomberg School of Public Health and his MPH from the University of Kansas.